RPTX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
RPTX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Repare Therapeutics's institutional ownership is 76.51%.
Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Repare Therapeutics's Insider Ownership is 1.18%.
Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Repare Therapeutics's Float Percentage Of Total Shares Outstanding is 60.46%.
The historical data trend for Repare Therapeutics's Institutional Ownership can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Repare Therapeutics Historical Data
The historical data trend for Repare Therapeutics can be seen below:
2024-02-29 | 2024-03-31 | 2024-04-30 | 2024-05-31 | 2024-06-30 | 2024-07-31 | 2024-08-31 | 2024-09-30 | 2024-10-31 | 2024-11-30 | |
Institutional Ownership | 14.97 | 14.30 | 14.44 | 14.23 | 13.75 | 13.68 | 13.45 | 13.21 | 13.08 | 12.47 |
The percentage of shares that are owned by institutions out of the total shares outstanding.
Maria Koehler | officer: EVP, Chief Medical Officer | C/O REPARE THERAPEUTICS INC., 7210 FREDERICK-BANTING, SUITE 100, ST-LAURENT A8 H4S 2A1 |
Michael Zinda | officer: EVP, Chief Science Officer | C/O REPARE THERAPEUTICS INC., 7210 FREDERICK-BANTING, SUITE 100, ST-LAURENT A8 H4S 2A1 |
Steve Forte | officer: EVP, Chief Financial Officer | C/O REPARE THERAPEUTICS INC., 7210 FREDERICK-BANTING, SUITE 100, ST-LAURENT A8 H4S 2A1 |
Lloyd Mitchell Segal | officer: President and CEO | 2150 ST. ELZEAR BLVD. WEST, LAVAL A8 H7L 4A8 |
Biotechnology Value Fund L P | other: See Explanation of Responses | 44 MONTGOMERY STREET, 40TH FL, SAN FRANCISCO CA 94104 |
Susan Molineaux | director | C/O CALITHERA BIOSCIENCES, INC., 343 OYSTER POINT BLVD., SUITE 200, SOUTH SAN FRANCISCO CA 94080 |
Davis Jerel | director, 10 percent owner | ONE SANSOME STREET, SUITE 3630, SAN FRANCISCO CA 94104 |
Versant Vantage I, L.p. | 10 percent owner | ONE SANSOME, SUITE 1650, SAN FRANCISCO CA 94104 |
Versant Ventures V, Llc | 10 percent owner | ONE SANSOME STREET, SUITE 1650, SAN FRANCISCO CA 94104 |
Thomas Civik | director | C/O FOUNDATION MEDICINE, INC., 150 SECOND STREET, CAMBRIDGE MA 02141 |
Bvf Ii Gp Llc | other: See Explanation of Responses | 44 MONTGOMERY ST., 40TH FLOOR, SAN FRANCISCO CA 94104 |
Bvf Gp Holdings Llc | 10 percent owner | 44 MONTGOMERY ST., 40TH FLOOR, SAN FRANCISCO CA 94104 |
Bvf I Gp Llc | other: See Explanation of Responses | 44 MONTGOMERY ST., 40TH FLOOR, SAN FRANCISCO CA 94104 |
Bvf Partners Os Ltd. | other: See Explanation of Responses | P.O. BOX 309 UGLAND HOUSE, GRAND CAYMAN E9 KY1-1104 |
Bvf Partners L P/il | 10 percent owner | 44 MONTGOMERY ST., 40TH FLOOR, SAN FRANCISCO CA 94104 |
From GuruFocus
By Business Wire • 04-26-2024
By Business Wire • 08-06-2024
By Business Wire • 05-29-2024
By Business Wire • 10-14-2024
By GuruFocus Research • 02-28-2024
By PRNewswire • 03-12-2024
By Business Wire • 06-10-2024
By Business Wire • 06-03-2024
By Business Wire • 10-23-2024
By GuruFocus Research • 02-08-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.